The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73 billion (USD 11.6 million1) in four ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.

New data from Eli Lilly and Company showed Omvoh-treated patients with moderately to severely active ulcerative colitis (UC) and bowel urgency experienced early improvements in bowel urgency severity, ...

Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...

We are now working on TB detection and testing for multiple drug resistance. So the technology with which we started is now significantly generalised as a platform technology which requires ...

Diagnostics' products, including its in-development point-of-care molecular diagnostics system, in Saudi Arabia and 18 other MENA countries.

Most people who get infected with TB never manifest any symptoms. They have latent tuberculosis, and their immune systems ...

Diagnosing TB in children has long been a challenge, but that is set to change. qXR from Qure.ai is the first AI-enabled ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...